Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Advagraf in Kidney or Liver Transplantation in India
NCT02432053Phase 4Completed
- Sponsor
- Astellas Pharma
- Start
- Mar 2012
- Primary completion
- May 2013
- Modality
- RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tacrolimus in kidney transplant rejection, Liver transplant rejection, sponsored by Astellas Pharma. Started Mar 2012; status: completed.
02
Drugs
tacrolimus
03
Conditions
kidney transplant rejectionLiver transplant rejection
Beyond the preview
Go deeper on NCT02432053.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02432053.